Copyright Reports & Markets. All rights reserved.

Global Nucleic Acid Delivery Excipients Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Nucleic Acid Delivery Excipients
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Nucleic Acid Delivery Excipients Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Cationic Lipids
    • 1.3.3 pH-sensitive Lipids
    • 1.3.4 Phospholipids
    • 1.3.5 PEG Lipids
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Nucleic Acid Delivery Excipients Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Lipid Nanoparticles for mRNA/siRNA/DNA
    • 1.4.3 Transfection Vectors for Gene Therapies
    • 1.4.4 Immunotherapies (CAR-T-Cells)
    • 1.4.5 Lipid Prodrugs
    • 1.4.6 Liposome Vectorization for Oncology
    • 1.4.7 Others
  • 1.5 Global Nucleic Acid Delivery Excipients Market Size & Forecast
    • 1.5.1 Global Nucleic Acid Delivery Excipients Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Nucleic Acid Delivery Excipients Sales Quantity (2018-2029)
    • 1.5.3 Global Nucleic Acid Delivery Excipients Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Avanti Polar Lipids
    • 2.1.1 Avanti Polar Lipids Details
    • 2.1.2 Avanti Polar Lipids Major Business
    • 2.1.3 Avanti Polar Lipids Nucleic Acid Delivery Excipients Product and Services
    • 2.1.4 Avanti Polar Lipids Nucleic Acid Delivery Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Avanti Polar Lipids Recent Developments/Updates
  • 2.2 Alfa Chemistry
    • 2.2.1 Alfa Chemistry Details
    • 2.2.2 Alfa Chemistry Major Business
    • 2.2.3 Alfa Chemistry Nucleic Acid Delivery Excipients Product and Services
    • 2.2.4 Alfa Chemistry Nucleic Acid Delivery Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Alfa Chemistry Recent Developments/Updates
  • 2.3 Evonik Health Care
    • 2.3.1 Evonik Health Care Details
    • 2.3.2 Evonik Health Care Major Business
    • 2.3.3 Evonik Health Care Nucleic Acid Delivery Excipients Product and Services
    • 2.3.4 Evonik Health Care Nucleic Acid Delivery Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Evonik Health Care Recent Developments/Updates
  • 2.4 Phosphorex
    • 2.4.1 Phosphorex Details
    • 2.4.2 Phosphorex Major Business
    • 2.4.3 Phosphorex Nucleic Acid Delivery Excipients Product and Services
    • 2.4.4 Phosphorex Nucleic Acid Delivery Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Phosphorex Recent Developments/Updates
  • 2.5 Creative Biolabs
    • 2.5.1 Creative Biolabs Details
    • 2.5.2 Creative Biolabs Major Business
    • 2.5.3 Creative Biolabs Nucleic Acid Delivery Excipients Product and Services
    • 2.5.4 Creative Biolabs Nucleic Acid Delivery Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Creative Biolabs Recent Developments/Updates
  • 2.6 Celares
    • 2.6.1 Celares Details
    • 2.6.2 Celares Major Business
    • 2.6.3 Celares Nucleic Acid Delivery Excipients Product and Services
    • 2.6.4 Celares Nucleic Acid Delivery Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Celares Recent Developments/Updates
  • 2.7 VectorBuilder
    • 2.7.1 VectorBuilder Details
    • 2.7.2 VectorBuilder Major Business
    • 2.7.3 VectorBuilder Nucleic Acid Delivery Excipients Product and Services
    • 2.7.4 VectorBuilder Nucleic Acid Delivery Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 VectorBuilder Recent Developments/Updates
  • 2.8 Seqens
    • 2.8.1 Seqens Details
    • 2.8.2 Seqens Major Business
    • 2.8.3 Seqens Nucleic Acid Delivery Excipients Product and Services
    • 2.8.4 Seqens Nucleic Acid Delivery Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Seqens Recent Developments/Updates
  • 2.9 BroadPharm
    • 2.9.1 BroadPharm Details
    • 2.9.2 BroadPharm Major Business
    • 2.9.3 BroadPharm Nucleic Acid Delivery Excipients Product and Services
    • 2.9.4 BroadPharm Nucleic Acid Delivery Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 BroadPharm Recent Developments/Updates
  • 2.10 Entos
    • 2.10.1 Entos Details
    • 2.10.2 Entos Major Business
    • 2.10.3 Entos Nucleic Acid Delivery Excipients Product and Services
    • 2.10.4 Entos Nucleic Acid Delivery Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Entos Recent Developments/Updates
  • 2.11 Gattefossé
    • 2.11.1 Gattefossé Details
    • 2.11.2 Gattefossé Major Business
    • 2.11.3 Gattefossé Nucleic Acid Delivery Excipients Product and Services
    • 2.11.4 Gattefossé Nucleic Acid Delivery Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Gattefossé Recent Developments/Updates

3 Competitive Environment: Nucleic Acid Delivery Excipients by Manufacturer

  • 3.1 Global Nucleic Acid Delivery Excipients Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Nucleic Acid Delivery Excipients Revenue by Manufacturer (2018-2023)
  • 3.3 Global Nucleic Acid Delivery Excipients Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Nucleic Acid Delivery Excipients by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Nucleic Acid Delivery Excipients Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Nucleic Acid Delivery Excipients Manufacturer Market Share in 2022
  • 3.5 Nucleic Acid Delivery Excipients Market: Overall Company Footprint Analysis
    • 3.5.1 Nucleic Acid Delivery Excipients Market: Region Footprint
    • 3.5.2 Nucleic Acid Delivery Excipients Market: Company Product Type Footprint
    • 3.5.3 Nucleic Acid Delivery Excipients Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Nucleic Acid Delivery Excipients Market Size by Region
    • 4.1.1 Global Nucleic Acid Delivery Excipients Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Nucleic Acid Delivery Excipients Consumption Value by Region (2018-2029)
    • 4.1.3 Global Nucleic Acid Delivery Excipients Average Price by Region (2018-2029)
  • 4.2 North America Nucleic Acid Delivery Excipients Consumption Value (2018-2029)
  • 4.3 Europe Nucleic Acid Delivery Excipients Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Nucleic Acid Delivery Excipients Consumption Value (2018-2029)
  • 4.5 South America Nucleic Acid Delivery Excipients Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Nucleic Acid Delivery Excipients Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Nucleic Acid Delivery Excipients Sales Quantity by Type (2018-2029)
  • 5.2 Global Nucleic Acid Delivery Excipients Consumption Value by Type (2018-2029)
  • 5.3 Global Nucleic Acid Delivery Excipients Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Nucleic Acid Delivery Excipients Sales Quantity by Application (2018-2029)
  • 6.2 Global Nucleic Acid Delivery Excipients Consumption Value by Application (2018-2029)
  • 6.3 Global Nucleic Acid Delivery Excipients Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Nucleic Acid Delivery Excipients Sales Quantity by Type (2018-2029)
  • 7.2 North America Nucleic Acid Delivery Excipients Sales Quantity by Application (2018-2029)
  • 7.3 North America Nucleic Acid Delivery Excipients Market Size by Country
    • 7.3.1 North America Nucleic Acid Delivery Excipients Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Nucleic Acid Delivery Excipients Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Nucleic Acid Delivery Excipients Sales Quantity by Type (2018-2029)
  • 8.2 Europe Nucleic Acid Delivery Excipients Sales Quantity by Application (2018-2029)
  • 8.3 Europe Nucleic Acid Delivery Excipients Market Size by Country
    • 8.3.1 Europe Nucleic Acid Delivery Excipients Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Nucleic Acid Delivery Excipients Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Nucleic Acid Delivery Excipients Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Nucleic Acid Delivery Excipients Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Nucleic Acid Delivery Excipients Market Size by Region
    • 9.3.1 Asia-Pacific Nucleic Acid Delivery Excipients Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Nucleic Acid Delivery Excipients Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Nucleic Acid Delivery Excipients Sales Quantity by Type (2018-2029)
  • 10.2 South America Nucleic Acid Delivery Excipients Sales Quantity by Application (2018-2029)
  • 10.3 South America Nucleic Acid Delivery Excipients Market Size by Country
    • 10.3.1 South America Nucleic Acid Delivery Excipients Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Nucleic Acid Delivery Excipients Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Nucleic Acid Delivery Excipients Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Nucleic Acid Delivery Excipients Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Nucleic Acid Delivery Excipients Market Size by Country
    • 11.3.1 Middle East & Africa Nucleic Acid Delivery Excipients Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Nucleic Acid Delivery Excipients Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Nucleic Acid Delivery Excipients Market Drivers
  • 12.2 Nucleic Acid Delivery Excipients Market Restraints
  • 12.3 Nucleic Acid Delivery Excipients Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Nucleic Acid Delivery Excipients and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Nucleic Acid Delivery Excipients
  • 13.3 Nucleic Acid Delivery Excipients Production Process
  • 13.4 Nucleic Acid Delivery Excipients Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Nucleic Acid Delivery Excipients Typical Distributors
  • 14.3 Nucleic Acid Delivery Excipients Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Nucleic Acid Delivery Excipients market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
    Nucleic acids, including plasmid DNA, oligonucleotides, small interfering RNA, messenger RNA and micro RNA provide significant promise in the treatment of challenging diseases. Unfortunately, their delivery as therapeutic agents has been a challenge. Nanoparticulate delivery systems, in which cationic lipids or polymers condense nucleic acids to form “lipoplex” or “polyplex” via the negative phosphate groups of nucleic acids show high productivity and loading efficiency. The intracellular delivery of these complexes is believed to occur via endocytosis followed by endosomal escape into the cytoplasm.
    The Global Info Research report includes an overview of the development of the Nucleic Acid Delivery Excipients industry chain, the market status of Lipid Nanoparticles for mRNA/siRNA/DNA (Cationic Lipids, pH-sensitive Lipids), Transfection Vectors for Gene Therapies (Cationic Lipids, pH-sensitive Lipids), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nucleic Acid Delivery Excipients.
    Regionally, the report analyzes the Nucleic Acid Delivery Excipients markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nucleic Acid Delivery Excipients market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Nucleic Acid Delivery Excipients market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nucleic Acid Delivery Excipients industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (kg), revenue generated, and market share of different by Type (e.g., Cationic Lipids, pH-sensitive Lipids).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nucleic Acid Delivery Excipients market.
    Regional Analysis: The report involves examining the Nucleic Acid Delivery Excipients market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nucleic Acid Delivery Excipients market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Nucleic Acid Delivery Excipients:
    Company Analysis: Report covers individual Nucleic Acid Delivery Excipients manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nucleic Acid Delivery Excipients This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Lipid Nanoparticles for mRNA/siRNA/DNA, Transfection Vectors for Gene Therapies).
    Technology Analysis: Report covers specific technologies relevant to Nucleic Acid Delivery Excipients. It assesses the current state, advancements, and potential future developments in Nucleic Acid Delivery Excipients areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nucleic Acid Delivery Excipients market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Nucleic Acid Delivery Excipients market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Cationic Lipids
    pH-sensitive Lipids
    Phospholipids
    PEG Lipids
    Market segment by Application
    Lipid Nanoparticles for mRNA/siRNA/DNA
    Transfection Vectors for Gene Therapies
    Immunotherapies (CAR-T-Cells)
    Lipid Prodrugs
    Liposome Vectorization for Oncology
    Others
    Major players covered
    Avanti Polar Lipids
    Alfa Chemistry
    Evonik Health Care
    Phosphorex
    Creative Biolabs
    Celares
    VectorBuilder
    Seqens
    BroadPharm
    Entos
    Gattefossé
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Nucleic Acid Delivery Excipients product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Nucleic Acid Delivery Excipients, with price, sales, revenue and global market share of Nucleic Acid Delivery Excipients from 2018 to 2023.
    Chapter 3, the Nucleic Acid Delivery Excipients competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Nucleic Acid Delivery Excipients breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Nucleic Acid Delivery Excipients market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Nucleic Acid Delivery Excipients.
    Chapter 14 and 15, to describe Nucleic Acid Delivery Excipients sales channel, distributors, customers, research findings and conclusion.

    Buy now